Equities

Well Lead Medical Co Ltd

603309:SHH

Well Lead Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)10.19
  • Today's Change-3.85 / -27.42%
  • Shares traded2.55m
  • 1 Year change-28.34%
  • Beta0.7157
Data delayed at least 15 minutes, as of Sep 13 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Well Lead Medical Co Ltd had revenues remain flat at 1.36bn, though the company grew net income 15.56% from 166.57m to 192.49m. A reduction in the cost of goods sold as a percentage of sales from 57.58% to 54.96% was a component in the net income growth despite flat revenues.
Gross margin44.37%
Net profit margin15.29%
Operating margin17.66%
Return on assets8.81%
Return on equity11.94%
Return on investment10.56%
More ▼

Cash flow in CNYView more

In 2023, cash reserves at Well Lead Medical Co Ltd fell by 88.57m. However, the company earned 222.51m from its operations for a Cash Flow Margin of 16.03%. In addition the company generated 11.66m cash from financing while 324.45m was spent on investing.
Cash flow per share--
Price/Cash flow per share--
Book value per share6.27
Tangible book value per share4.73
More ▼

Balance sheet in CNYView more

Well Lead Medical Co Ltd has a Debt to Total Capital ratio of 23.18%, a higher figure than the previous year's 12.58%.
Current ratio1.90
Quick ratio1.49
Total debt/total equity0.3042
Total debt/total capital0.2318
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 47.06% and 14.76%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is above the industry average relative to its peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)1.80%
Div growth rate (5 year)45.41%
Payout ratio (TTM)68.08%
EPS growth(5 years)21.28
EPS (TTM) vs
TTM 1 year ago
24.40
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.